Nu Skin Adds Galvanic Body Device, R2 Supplement To ageLOC Line
This article was originally published in The Rose Sheet
Executive Summary
Building on its profitable ageLOC portfolio, which has generated $700 million in sales in the short three-year span the products have been on the market, Nu Skin Enterprise, Inc. launches two new products this month. The ageLOC Galvanic Body Spa skin-treatment system (with accompanying body-shaping gel and body-contouring lotion) will bow in the U.S., Europe and South Pacific markets, while the ageLOC R2 supplement system is rolling out in Japan and Korea.
You may also be interested in...
Nu Skin Unfazed By Allegations Of China Violations, Projects More Growth
Following allegations from short seller Citron Research that it operates an illegal “pyramid compensation scheme” in China, Nu Skin gives investors a peek into its business model. The firm recorded sales growth of 40% in its second quarter, driven by a 152% jump in China, and “the best is yet to come,” Nu Skin says.
Sales & Earnings In Brief
GSK core OTCs outpace market growth; Sanofi consumer business surges in emerging markets; broad drivers fuel GNC growth; USANA builds bonds in China; bullish Mead Johnson raises outlook; more Sales & Earnings In Brief.
Sales & Earnings In Brief
GSK core OTCs outpace market growth; Sanofi consumer business surges in emerging markets; broad drivers fuel GNC growth; USANA builds bonds in China; bullish Mead Johnson raises outlook; more Sales & Earnings In Brief.